| 14.02 |  0.00 / 0.00% |
Data as of 4:00pm ET | Day’s Change |
| 14.02 |  +0.0028 / +0.02% |
Volume: 1.5K |
| Previous close | 14.02 |
| Today’s open | 13.91 |
| Day’s range | 13.80 - 14.15 |
| Volume | 137,604 |
| Average volume (3 months) | 296,427 |
| Market cap | $504.3M |
| Dividend yield | -- |
| Earnings growth (last year) | +65.71% |
| Earnings growth (this year) | +9.03% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +18,055.99% |
| P/E ratio | NM |
| Price/Sales | 9.28 |
| Price/Book | 5.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNTASynta Pharmaceutical... | +0.26 | +3.56% |
| SGNTSagent Pharmaceutica... | -0.14 | -0.78% |
| MACKMerrimack Pharmaceut... | -0.06 | -1.14% |
| NDZNordion Inc | -0.22 | -2.74% |
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $34.7M |
| Annual profit (last year) | -$17.3M |
| Net profit margin | -49.86% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director P. Ron Ellis, MBA |
Chief Financial Officer Michael A. Sherman, MBA |
Corporate headquarters West Lafayette, Indiana |
.
